Latest news with #2027
The Sun
an hour ago
- Sport
- The Sun
Time for Harimau Malaya to rewrite history against Vietnam
NATIONAL head coach Peter Cklamovski has recognised the tough challenge ahead as Harimau Malaya aim to overturn more than a decade of winless results against Vietnam in their crucial Group F 2027 Asian Cup qualifier next Tuesday (June 10). The Australian coach said he respects Vietnam but is determined to make history with Malaysia. 'Malaysia hasn't beaten Vietnam for over 10 years. That's more than a decade and this is a moment we want to overturn and change a bit of history. 'So full respect to Vietnam. I don't focus on one player (opponent); I focus on the whole team. We look forward to the challenge on June 10th,' the 46-year-old coach told reporters when met during the national team's training session, which was also attended by Vietnamese media here, today. At the same time, he praised Vietnam who are led by South Korean Kim Sang Sik as a strong and skilful side, adding that he has studied the entire squad. 'I've watched all of them. They're a very good team, a strong squad. Full respect to Vietnam - they're a very good footballing side,' he said. Vietnam and Malaysia jointly top the group with three points each after winning their opening matches. For the record, the last time Malaysia defeated the Golden Star Warriors was in 2014 before suffering seven defeats and managing just one draw in their eight meetings across all competitions since. The last time the two teams met, Vietnam secured a 3-0 victory in the group stage of the 2022 ASEAN Football Federation (AFF) Cup, now known as the ASEAN Championship. Cklamovski's men will face world number 72 ranked Cape Verde in a closed door friendly at the National Stadium in Bukit Jalil here, tomorrow night after the two sides played out a 1-1 draw in their Tier 1 international match at the Kuala Lumpur Football Stadium in Cheras, last Thursday.
Daily Mail
a day ago
- Business
- Daily Mail
Now Rachel Reeves is coming for your PENSION: the Chancellor wants to get her hands on up to 87% of your life savings with a vicious new tax raid - here's how to stop her: ELIZABETH ANDERSON
Have you saved wisely, invested well and built up a healthy pension to enjoy in retirement and pass down to your loved ones? Then beware. Up to 87 per cent of it could be swallowed up in tax when you die once new inheritance tax rules are introduced in 2027, Wealth & Personal Finance can reveal in our new calculations.
Yahoo
2 days ago
- Business
- Yahoo
Gap's Earnings to be Weighed Down Amid Larger-Than-Expected Tariff Headwinds, UBS Says
Gap's (GAP) earnings through 2027 are likely to take a hit amid larger-than-projected headwinds from Sign in to access your portfolio
Yahoo
3 days ago
- Business
- Yahoo
Fulcrum Therapeutics, Inc. (FULC): A Bull Case Theory
We came across a bullish thesis on Fulcrum Therapeutics, Inc. (FULC) on Stock Pursuit's Substack. In this article, we will summarize the bulls' thesis on FULC. Fulcrum Therapeutics, Inc. (FULC)'s share was trading at $6.44 as of 23rd May. FULC's trailing P/E was 312.50 according to Yahoo Finance. A scientist in a lab conducting research on cell-based therapeutics and biotechnology. Fulcrum Therapeutics (FULC) recently surged over 110% from around $3.30 to $7.00, reflecting growing optimism but also presenting a prime opportunity to take profits. The company's lead candidate, Pociredir (FTX-6058), is an oral small molecule in Phase 1b trials aimed at treating Sickle Cell Disease (SCD) by increasing fetal hemoglobin expression. While early data are encouraging, larger trials are needed to confirm efficacy and safety, especially following a prior clinical hold related to concerns over EED inhibitors. Analysts have raised their peak sales forecasts to roughly $600 million with a 50% probability of success, and Fulcrum's cash runway extends into 2027. Market dynamics favor Pociredir due to Pfizer's withdrawal of Oxbryta and slow adoption of gene therapies, creating scarcity value for new oral treatments. Beyond SCD, Fulcrum is developing programs for inherited aplastic anemias, with an Investigational New Drug application for Diamond-Blackfan anemia expected in late 2025. Despite this promise, history shows that small-cap pharma stocks can experience volatile reversals after big gains, so locking in profits while retaining a small position for potential upside on drug results seems prudent. The broader biotech sector, historically avoided by the author, has recently become more attractive due to technological advances and compelling net cash positions, as demonstrated by previous successes like Somalogic. Overall, Fulcrum represents a high-risk, high-reward opportunity in a niche with growing unmet medical needs, but caution and disciplined profit-taking remain essential given the sector's volatility. Fulcrum Therapeutics, Inc. (FULC) is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 21 hedge fund portfolios held FULC at the end of the first quarter which was 23 in the previous quarter. While we acknowledge the risk and potential of FULC as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than FULC but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock. READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock. Disclosure: None. This article was originally published at Insider Monkey.
Daily Mail
3 days ago
- Lifestyle
- Daily Mail
Footy legend Tim Horan says Nathan Cleary is keen to make bombshell move that would send shockwaves through Aussie sport
Wallabies legend Tim Horan has dropped a bombshell after declaring NRL superstar Nathan Cleary is 'quite keen to come to rugby.' It isn't the first time the Panthers halfback has been linked to a shock cross-code switch, and with his girlfriend, Matildas star Mary Fowler based in England, the 27-year-old may seek a bold new sporting challenge abroad. Signing on with Rugby Australia is another option - and with the next World Cup on local shores in 2027, rugby fans are hopeful. Speaking on Stan Sport 's Rugby Heaven, dual World Cup winner Horan said the move for Cleary could materialise. 'There's been some rumours the last two months that he's quite keen,' the decorated inside centre said. 'I've heard it totally separate, he's quite keen to come to rugby.' Horan added that RA shouldn't be raiding the NRL for talent - before adding that if a player of Cleary's calibre was interested, 'you've got to have a coffee.' Cleary made his NRL debut in 2016, and has gone onto win four premierships with the Panthers. Nathan Cleary and Matildas star Mary Fowler have been Australian sport's power couple since 2023 He won a World Cup with the Kangaroos in 2022 - and has also chalked up 15 appearances for NSW at Origin level since 2018. Cleary's current NRL contract with Penrith expires at the end of 2027 - and he also previously stated he would be 'open' to new surroundings overseas. 'I'm not against it,' he said. 'I have a pretty open mind to that kind of stuff. 'Being able to experience different cultures is something I enjoy doing.' Adding to the intrigue is Fowler recently confirming she has no desire to play in the A-League Women's competition. 'I'm not going to be playing football in Australia anytime soon, if ever,' the Matildas star said.
